With reference to its intimation dated May 31, 2022 regarding Earnings Presentation for Quarter 4- Financial Year 2021-2022, Fermenta Biotech has informed that there was a typographical error on page 6 – para 2 ‘Q4-FY22 Operational Highlights’ of the said Earnings Presentation. In view of above, the company has enclosed the revised Earnings Presentation for Quarter 4- Financial Year 2021-2022 for the record. Except the said revision on page 6- para 2 ‘Q4-FY22 Operational Highlights’, all other details remain unchanged. The revised Earnings Presentation will thereafter be uploaded on Company’s website at www.fermentabiotech.com.
The above information is a part of company’s filings submitted to BSE.
